ClinicalTrials.govpublic full text
PRJ2203: Dolutegravir Post Authorization Safety Study (PASS)
infection, human immunodeficiency virus i, hypersensitivity reactions (hsr), hiv, dolutegravir, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 856501
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.